Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trial. (linkinghub.elsevier.com)

Authors: Lorusso D … Olawaiye AB Journal: The Lancet Published: 2026-04-18 DOI: https://doi.org/10.1016/S0140-6736(26)00462-9